​

Funding Round

Series B - Eligo Bioscience

Series B - Eligo Bioscience

Investment Firm

Overview

Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.

Announced Date

Dec 05, 2023

Funding Type

Series B

Highlights

Location

Europe

Social

Investor Lead

Sanofi Ventures

Sanofi Ventures

Sanofi Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorSanofi Ventures
Participant InvestorBpifrance
Participant InvestorSeventure Partners
Participant InvestorKhosla Ventures

Round Details and Background

Eligo Bioscience raised $29900691 on 2023-12-05 in Series B

Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 05, 2023
Series B - Eligo Bioscience
4-29.9M
Sep 26, 2017
Grant - Eligo Bioscience
1-2.0M
Sep 26, 2017
Series A - Eligo Bioscience
2-18.0M
Jul 09, 2015
Seed Round - Eligo Bioscience
2-2.9M

Recent Activity

There is no recent news or activity for this profile.